{"disease":{"id":"hemophagocytic-lymphohistiocytosis-hlh","name":"hemophagocytic lymphohistiocytosis hlh"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06951971","title":"Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT02472054","title":"Treatment of Familiar Lymphohistiocytosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07525466","title":"Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT07531069","title":"Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Fudan University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}